Rapid Tests Market Report 2026

Rapid Tests Market Overview

• Rapid Tests market size has reached to $34.67 billion in 2025 • Expected to grow to $59.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.2% • Growth Driver: Rising Incidence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Need For Timely Diagnosis And Containment • Market Trend: Bioluminescence Innovation Enhances Microbial Testing Accuracy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rapid Tests Market?

Rapid tests are diagnostic tools designed to detect specific diseases or conditions quickly, typically within minutes to an hour, without the need for complex laboratory equipment. They are typically easy to use, require minimal equipment, and can be performed at the point of care, such as clinics, pharmacies, or even at home. The main purpose of rapid tests is to enable quick, point-of-care diagnosis, facilitating timely treatment decisions and disease control. The main product types of rapid tests include instruments, consumables, and others. Instruments refer to devices used for analyzing samples, including portable analyzers, benchtop analyzers, handheld devices, readers or scanners, and multiplex analyzers. These are categorized by contaminants into pathogens, allergens, meat speciation, and pesticides and utilize various technologies such as polymerase chain reaction (PCR), immunoassay-based, chromatography-based, and spectroscopy-based methods. Rapid tests find applications in cardiology, oncology, pregnancy and fertility, toxicology, glucose monitoring, infectious disease, and others, serving key end users such as hospitals and clinics, diagnostic laboratories, home care, and others.

What Is The Rapid Tests Market Growth Forecast?

The rapid tests market size is expected to see rapid growth in the next few years. It will grow to $59.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to integration of ai and iot in rapid tests, rising adoption of home healthcare solutions, development of multiplex testing kits, expansion of personalized medicine, government initiatives supporting point-of-care diagnostics. Major trends in the forecast period include point-of-care testing expansion, miniaturization of diagnostic devices, rapid infectious disease screening, home-based diagnostic solutions, cost-effective testing solutions.

Global Rapid Tests Market Segmentation

1) By Product: Instruments, Consumables, Other Products 2) By Contaminants: Pathogens, Allergens 3) By Technology: Polymerase Chain Reaction (PCR)-Based, Immunoassay-Based, Chromatography-Based 4) By Application: Cardiology, Oncology, Pregnancy And Fertility, Toxicology, Glucose Monitoring, Infectious Disease, Other Applications 5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End-Users Subsegments: 1) By Instruments: Portable Analyzers, Benchtop Analyzers, Handheld Devices, Readers Or Scanners, Multiplex Analyzers 2) By Consumables: Test Strips, Test Cassettes Or Cartridges, Reagents, Sample Collection Devices, Control And Calibration Materials 3) By Other Products: Software And Data Management Systems, Accessories, Maintenance And Service Kits

What Is The Driver Of The Rapid Tests Market?

The rising incidence of infectious diseases is expected to propel the growth of the rapid tests market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The rising prevalence of infectious diseases is due to increasing travel, which facilitates the rapid spread of pathogens across borders. Rapid tests help combat infectious diseases by enabling quick and accurate detection at the point of care, allowing for timely treatment and isolation. They support public health responses by reducing diagnostic delays, improving disease management, and limiting the spread of infections. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the rising incidence of infectious diseases is driving the growth of the rapid tests industry.

Key Players In The Global Rapid Tests Market

Major companies operating in the rapid tests market are F Hoffmann La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens Healthineers, BioMerieux SA, Quidel Corporation, Bio Rad Laboratories Inc, PerkinElmer Inc, OraSure Technologies Inc, SEKISUI Diagnostics LLC, Trivitron Healthcare Pvt Ltd, Ellume Limited, Access Bio Inc, ACON Laboratories Inc, CTK Biotech Inc, iHealth Labs Inc, Wondfo USA Co Ltd, InBios International Inc, Lab Care Diagnostics India Pvt Ltd, Immunostics Inc, Aptitude Medical Systems Inc, Beijing Hotgen Biotech Co Ltd, CorDx Inc, Maxim Biomedical Inc, OSANG LLC

Global Rapid Tests Market Trends and Insights

Major companies operating in the rapid tests market are focusing on developing technologically advanced solutions, such as advanced bioluminescence technology, to enable faster, more sensitive, and accurate pathogen detection. Advanced bioluminescence technology refers to the use of light-emitting biochemical reactions, typically involving luciferase enzymes and substrates, to detect the presence of microorganisms or biological markers. For instance, in March 2025, Nelson Labs, a US-based testing services provider, launched a rapid sterility testing method. This new testing method reduces the traditional 14-day incubation period to as little as six days using advanced bioluminescence technology. This system detects microbial adenosine triphosphate (ATP), a marker of living organisms, by measuring the light emitted during the bioluminescent reaction. It automates detection of microbial contamination, enhances accuracy, and ensures regulatory compliance, enabling faster, reliable product release without compromising safety.

What Are Latest Mergers And Acquisitions In The Rapid Tests Market?

In June 2023, Avacta Group plc, a UK-based life sciences company, acquired Coris Bioconcept SRL for $13.21 million (£10.4 million). With this acquisition, Avacta expanded its presence in the rapid diagnostics market, strengthened its in vitro diagnostics (IVD) capabilities, and gained access to Coris’s established lateral flow test product portfolio and distribution network across Europe and other global markets. Coris Bioconcept SRL is a Belgium-based company specializing in rapid diagnostic tests.

Regional Outlook

North America was the largest region in the rapid tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Rapid Tests Market?

The rapid tests market consists of revenues earned by entities by providing services such as point-of-care diagnostics, on-site screening, home-based testing, mobile health testing units, and diagnostic support for early disease detection and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The rapid tests market also includes sales of rapid diagnostic kits, test strips, reagents, lateral flow assays, analyzers, and related consumables used for the detection of various diseases and conditions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.